drug · small molecule
fasedienol
Phase 3updated 3mo agoby $VTGN Vistagen Therapeutics, Inc.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 5 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying fasedienol
- phase3Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
- phase2A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
- phase3Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
News(3)
- Aura, Schrödinger trim workforcesFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 1d ago
- Vistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage studyThe Phase 2 study was small and was not designed to establish the statistical difference between Vistagen’s drug candidate and placebo, according to Vistagen. The biotech plans to meet with the FDA…biospace · 5d ago
- Double shot of Vistagen’s anxiety nasal spray can’t beat placebo in ph. 2 trialFollowing a string of clinical setbacks, Vistagen’s nasal spray for social anxiety has now failed to top placebo even when given as a double dose. But just like with prior disappointing readouts, t…fiercebiotech · 6d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that